Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 9/20 | 0.46 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.46 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38650823 | 0.97 | BACE1 (0.44) | BACE1BACE2CTSD | |
| SCHEMBL29678408 | 0.95 | PSEN1 (0.45) | BACE1BACE2 | |
| SCHEMBL38656914 | 0.88 | PSEN1 (0.47) | BACE1BACE2 | |
| SCHEMBL38651067 | 0.88 | KISS1R (0.43) | BACE1BACE2CTSD | |
| SCHEMBL29678374 | 0.83 | OPRM1 (0.52) | — | |
| SCHEMBL29913453 | 0.82 | MMP2 (0.46) | — | |
| SCHEMBL29612276 | 0.82 | BACE1 (0.54) | BACE1BACE2CTSD | |
| SCHEMBL29973377 | 0.81 | OPRM1 (0.56) | BACE1BACE2 | |
| SCHEMBL30785947 | 0.80 | OPRK1 (0.59) | BACE1BACE2CTSD | |
| SCHEMBL29568803 | 0.80 | BACE1 (0.50) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011101-A | N-terminal lauroyl modified LMN-NKA polypeptide derivative, pharmaceutically acceptable salt thereof and preparation method | 橡果美健实业投资股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122011101-A | N-terminal lauroyl modified LMN-NKA polypeptide derivative, pharmaceutically acceptable salt thereof and preparation method | 橡果美健实业投资股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122011100-A | N-terminal palmitoylation/C-terminal ethylamino double-modified LMN-NKA polypeptide derivative, pharmaceutically acceptable salt thereof and preparation method thereof | 橡果美健实业投资股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121949459-A | N-terminal lauroyl/C-terminal ethylamino double-modified LMN-NKA polypeptide derivative, pharmaceutically acceptable salt thereof and preparation method | 橡果美健实业投资股份有限公司 | 2026-05-01 | — | — | CN | disclosed |
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |